Showing results (681-690 of 1,022) with videos related to

Sort By:
Pageof 103
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2008
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patientsF Cappuzzo, P A Jänne, M Skokan, et al.
Plos Neglected Tropical Diseases|January 21, 2025
Longitudinal observational (single cohort) study on the causes of trypanocide failure in cases of African animal trypanosomosis in cattle near wildlife protected areas of Northern TanzaniaShauna Richards, Davide Pagnossin, Paul Samson Buyugu, et al.
Cell|April 9, 2008
RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin miceWilliam J Durham, Paula Aracena-Parks, Cheng Long, et al.
Journal of Endocrinological Investigation|July 2, 2022
Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatmentF Mazzoli, E Cassioli, J Ristori, et al.
Biochemical Pharmacology|September 18, 2018
LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiationE Zulato, F Ciccarese, V Agnusdei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2007
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patientsF Cappuzzo, G Finocchiaro, E Rossi, et al.
British Journal of Cancer|November 17, 2005
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patientsF Cappuzzo, L Toschi, I Domenichini, et al.
Journal of Applied Microbiology|December 16, 2020
Detection of environmental contamination with feline and canine parvoviruses: new perspectives and challengesM L Marenzoni, M B Conti, E Rossi, et al.
Pathologica|April 11, 2001
[The STF Project: Female Tumor Screening]M Branca, E Rossi, S Cedri, et al.
British Journal of Cancer|April 20, 2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trialC Pacilio, A Morabito, F Nuzzo, et al.
Pageof 103